Microvascular capillaroscopic abnormalities and occurrence of antinuclear autoantibodies in patients with sarcoidosis.
Francesco CattelanElvis HysaEmanuele GotelliCarmen PizzorniPietro Francesco BicaMarco GrossoEmanuela BarisioneSabrina PaolinoLuca CarmiscianoAlberto SulliVanessa SmithMaurizio CutoloPublished in: Rheumatology international (2022)
We described nailfold videocapillaroscopy (NVC) findings and estimated the prevalence of serum anti-nuclear (ANA) and extractable nuclear antigen autoantibodies (ENA) in a cohort of sarcoidosis patients, comparing them with adequate healthy controls (HCs) and with primary Raynaud's phenomenon patients (PRPs). NVC findings were also correlated with the occurrence of autoantibodies, current treatment, laboratory parameters, variables of lung function and whole-body imaging data. Twenty-six patients with sarcoidosis were assessed through NVC, laboratory parameters, pulmonary function tests, chest-X ray and 18- fluorodeoxyglucose positron emission tomography/computed tomography. The NVC parameters and ANA/ENA dosage were recorded also in 30 PRPs and 30 HCs. Sarcoidosis patients showed a higher rate of capillary dilations and nonspecific abnormalities and a lower mean capillary absolute number than PRPs and HCs (p < 0.01 for all comparisons). The prevalence of ANA positivity was higher in patients with sarcoidosis compared with PRPs and HCs (p < 0.02 for both), whereas ENA positivity was detected in one sarcoidosis patient (Ro52). Among sarcoidosis patients, the mean capillary absolute number negatively correlated with the C-reactive protein concentrations and was positively associated with the forced vital capacity percentage. Instead, a negative correlation was detected between serum ACE levels and the presence of capillary dilations (all p < 0.05). Our findings suggest a microvascular involvement in sarcoidosis whose investigation by NVC might be useful for the follow-up of patients displaying RP. Autoantibody positivity in sarcoidosis might suggest autoimmune implications in the disease or the production of autoantibodies reactive to tissue damage.
Keyphrases
- magnetic resonance
- computed tomography
- end stage renal disease
- positron emission tomography
- ejection fraction
- newly diagnosed
- chronic kidney disease
- lung function
- multiple sclerosis
- peritoneal dialysis
- magnetic resonance imaging
- systemic lupus erythematosus
- risk factors
- systemic sclerosis
- patient reported outcomes
- mass spectrometry
- pet ct
- case report
- artificial intelligence
- deep learning
- patient reported
- angiotensin converting enzyme
- replacement therapy